Globe Life (GL) Expected to Announce Earnings on Wednesday

Globe Life (NYSE:GL) is expected to announce its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $3.12 per share and revenue of $1.48 billion for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Globe Life Trading Up 0.2 %

GL opened at $122.38 on Tuesday. Globe Life has a 12 month low of $38.95 and a 12 month high of $132.00. The stock has a market capitalization of $10.27 billion, a price-to-earnings ratio of 10.35 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The business has a fifty day moving average price of $112.33 and a 200 day moving average price of $106.17.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were paid a dividend of $0.24 per share. The ex-dividend date was Monday, January 6th. This represents a $0.96 annualized dividend and a yield of 0.78%. Globe Life’s payout ratio is 8.12%.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 13,448 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the sale, the chief executive officer now owns 18,948 shares in the company, valued at $2,132,786.88. This represents a 41.51 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CMO Jennifer Allison Haworth sold 9,000 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $112.91, for a total value of $1,016,190.00. Following the sale, the chief marketing officer now owns 13,485 shares in the company, valued at $1,522,591.35. The trade was a 40.03 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,788 shares of company stock worth $4,429,779. 1.51% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and upped their price objective for the stock from $132.00 to $143.00 in a research report on Wednesday, January 8th. TD Cowen assumed coverage on Globe Life in a research report on Wednesday, October 9th. They set a “buy” rating and a $150.00 price objective for the company. Wells Fargo & Company upped their price objective on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Truist Financial upped their target price on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, October 25th. Finally, Piper Sandler upped their target price on Globe Life from $118.00 to $130.00 and gave the company an “overweight” rating in a research report on Friday, October 25th. Five analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $132.18.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.